This early-stage study tested a new drug called ENV-294 in 9 adults with moderate-to-severe atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when taken daily for 28 days. Researchers also looked for any changes in eczema severity. This is a f…
Phase: PHASE1 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 11:36 UTC